Methamphetamine

1. 2026-10-19issueIssued info_card
2. 2026-10-19issueIssued notice
3. 2026-09-27runbrief run
4. 2026-09-27revisionr1.a1
5. 2026-09-24srcPharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
6. 2026-09-24srcSafety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances
7. 2026-09-24srcβ2AR as a target in methamphetamine addiction: Divergent mechanisms from TAAR1
8. 2026-09-24srcMethamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
9. 2026-09-24srcPersistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users
10. 2026-09-24srcSexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorder
11. 2026-09-24srcEffects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies
12. 2026-09-24srcThe Cardiac Complications of Methamphetamines
13. 2026-09-24srcAcute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline
14. 2026-09-24srcMolecular bases of methamphetamine-induced neurodegeneration
15. 2026-09-24srcAbsence of TAAR1 function increases methamphetamine-induced excitability of dorsal raphe serotonin neurons and drives binge-level methamphetamine intake
16. 2026-09-24srcRecognition of methamphetamine and other amines by trace amine receptor TAAR1
17. 2026-09-24srcMethamphetamine Consumption During Pregnancy and its Effects on Neonates
18. 2026-09-24srcEstimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose
19. 2026-09-24srcPsychosis in acute methamphetamine intoxication is usually self-limiting and can be managed in the emergency department: A retrospective series
20. 2026-09-24srcClinical management of psychostimulant withdrawal: review of the evidence
21. 2026-09-24srcPharmacotherapy of amphetamine-type stimulant dependence: an update
22. 2026-09-24srcPutting the call out for more research: the poor evidence base for treating methamphetamine withdrawal
23. 2026-09-24srcStudy protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings
24. 2026-09-24srcMethamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension
25. 2026-09-24srcStroke and methamphetamine use in young adults: a review
26. 2026-09-24srcReduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension
27. 2026-09-24srcEvidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology
28. 2026-09-24srcAppetite suppressants as agonist substitution therapies for stimulant dependence
29. 2026-09-24srcEffects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system
30. 2026-09-24srcStructural abnormalities in the brains of human subjects who use methamphetamine
31. 2026-09-24srcToxin-induced hyperthermic syndromes
32. 2026-09-24srcA lasting vulnerability to psychosis in patients with previous methamphetamine psychosis
33. 2026-09-24srcCauses and consequences of methamphetamine and MDMA toxicity
34. 2026-09-24srcHuman pharmacology of the methamphetamine stereoisomers
35. 2026-09-24srcNeurotoxicity of substituted amphetamines: molecular and cellular mechanisms
36. 2026-09-24srcInhibition of monoamine oxidase (MAO) by alpha-ethylphenethylamine and N,alpha-diethylphenethylamine, two compounds related to dietary supplements
37. 2026-09-24srcEnduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis
38. 2026-09-24srcAcute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis
39. 2026-09-24srcBiogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux
40. 2026-09-24srcAmphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport
41. 2026-09-24srcPharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride
42. 2026-09-24srcStroke associated with methamphetamine inhalation
43. 2026-09-24srcChemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol
44. 2026-09-24srcReduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428
45. 2026-09-24srcMethamphetamine — StatPearls
46. 2026-09-24srcUN 1971 Convention on Psychotropic Substances - methamphetamine Schedule II
47. 2026-09-04issueIssued emergency
48. 2026-09-04issueIssued info_card
49. 2026-09-04issueIssued notice
50. 2026-06-04proposal60 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
51. 2026-06-04publicationPublication — backfill
52. 2026-04-21proposalduration · insufflated · aftereffects
53. 2026-04-21proposalduration · insufflated · total
54. 2026-04-21proposalduration · insufflated · peak
55. 2026-04-21proposalduration · insufflated · come_up
56. 2026-04-21proposalduration · insufflated · onset
57. 2026-04-21proposalduration · smoked · aftereffects
58. 2026-04-21proposalduration · smoked · total
59. 2026-04-21proposalduration · smoked · offset
60. 2026-04-21proposalduration · smoked · peak
61. 2026-04-21proposalduration · smoked · come_up
62. 2026-04-21proposalduration · smoked · onset
63. 2026-04-21proposalduration · oral · aftereffects
64. 2026-04-21proposalduration · oral · total
65. 2026-04-21proposalduration · oral · offset
66. 2026-04-21proposalduration · oral · peak
67. 2026-04-21proposalduration · oral · come_up
68. 2026-04-21proposalduration · oral · onset
69. 2026-04-21proposaldosage · insufflated
70. 2026-04-21proposaldosage · smoked
71. 2026-04-21proposaldosage · oral
72. 2026-04-21proposaltolerance
73. 2026-04-21proposalwithdrawal
74. 2026-04-21proposaldependence · full
75. 2026-04-21proposaltoxicity
76. 2026-04-21proposaltimeline · insufflated · afterglow
77. 2026-04-21proposaltimeline · insufflated · resolution
78. 2026-04-21proposaltimeline · insufflated · peak
79. 2026-04-21proposaltimeline · insufflated · come_up
80. 2026-04-21proposaltimeline · insufflated · onset
81. 2026-04-21proposaltimeline · smoked · afterglow
82. 2026-04-21proposaltimeline · smoked · resolution
83. 2026-04-21proposaltimeline · smoked · peak
84. 2026-04-21proposaltimeline · smoked · come_up
85. 2026-04-21proposaltimeline · smoked · onset
86. 2026-04-21proposaltimeline · oral · afterglow
87. 2026-04-21proposaltimeline · oral · resolution
88. 2026-04-21proposaltimeline · oral · plateau
89. 2026-04-21proposaltimeline · oral · peak
90. 2026-04-21proposaltimeline · oral · come_up
91. 2026-04-21proposaltimeline · oral · onset
92. 2026-04-21proposaldose_tier · heavy
93. 2026-04-21proposaldose_tier · strong
94. 2026-04-21proposaldose_tier · common
95. 2026-04-21proposaldose_tier · light
96. 2026-04-21proposaldose_tier · threshold
97. 2026-04-21revisionRevision 1
98. 2026-04-21genGeneration — pipeline-v5 · with 1 morepipeline-v5
99. 2026-04-21rungeneration run

The same entries, as forms: six forms.